Shree ganesh remedies Limited has submitted the voting results of its Extra Ordinary General Meeting held on April 06, 2026, to BSE Limited in compliance with Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting, conducted through video conferencing from 12:30 p.m. to 01:10 p.m., addressed critical resolutions regarding leadership appointments and related party transactions with overwhelming shareholder support.

Meeting Overview and Participation

The Extra Ordinary General Meeting was conducted entirely through Video Conferencing and Other Audio-Visual Means, ensuring compliance with circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. The company reported strong participation from its shareholder base.

Resolution Results and Voting Outcomes

Both resolutions presented at the meeting received substantial approval from shareholders, demonstrating strong confidence in the company's governance decisions.

Resolution 1: Director Re-appointment

The special resolution for re-appointment of Mr. Parth Chandulal Kothia (DIN: 08830608) as Whole-time Director and CFO achieved remarkable support:

Resolution 2: Related Party Transaction

The ordinary resolution approving remuneration payment to Mr. Gunjan Chandulal Kothia also secured strong shareholder backing:

E-Voting Process and Scrutiny

The company provided comprehensive e-voting facilities through Central Depository Services (India) Limited (CDSL), enabling both remote e-voting prior to the meeting and e-voting during the EGM. CS Vishal Thawani of VTSN and Associates LLP served as the appointed Scrutinizer, ensuring fair and transparent voting procedures.

The voting process included shareholders holding shares as of the cut-off date of March 30, 2026, with a total of 12,837,620 shares eligible for voting. The overall voting participation rate stood at 6.95% of outstanding shares.

Regulatory Compliance and Documentation

Aditya Patel, Company Secretary and Compliance Officer, submitted the comprehensive voting results to BSE Limited, fulfilling regulatory requirements under SEBI LODR Regulations. The detailed scrutinizer's report and voting results have been made available on the company's website, ensuring transparency for all stakeholders.

The successful completion of the EGM and subsequent regulatory submissions demonstrate the company's commitment to corporate governance standards and regulatory compliance.

Shree Ganesh Remedies Limited has announced an Extraordinary General Meeting (EGM) scheduled for April 06, 2026 at 12:30 PM IST, to be conducted through video conferencing in compliance with regulatory guidelines. The pharmaceutical company has outlined two critical agenda items requiring shareholder approval and has published the official notice in newspapers on March 14, 2026.

Key Agenda Items

The EGM will address significant management appointments and related party transactions that are essential for the company's operational continuity.

Re-appointment of Whole-time Director

The primary agenda involves the re-appointment of Mr. Parth Chandulal Kothia (DIN: 08830608) as Whole-time Director and Chief Financial Officer. The proposed appointment details are:

Mr. Parth Kothia, aged 30 years, holds a B.Tech in Chemical Engineering and an MSc in Global Finance from Fordham University, USA. He has over five years of experience in business development for pharmaceutical intermediates and specialty chemicals, along with experience in the PE and venture capital industry in the USA. During FY 2024-25, he received remuneration of ₹ 96 lakhs plus ₹ 18 lakhs as incentive.

Related Party Transaction Approval

The second agenda item seeks approval for a related party transaction involving Mr. Gunjan Chandulal Kothia, son of Managing Director Mr. Chandulal Kothia and brother of Mr. Parth Kothia. The transaction details include:

Mr. Gunjan Kothia holds a Bachelor's degree in Chemical Engineering and a Master's degree in Science from the University of Leeds, United Kingdom. He brings valuable experience in research and development, having worked for two years in R&D in Organic Chemistry and five years in business development across pharmaceutical intermediates, specialty chemicals, and organic pigments.

E-voting and Meeting Procedures

The company has established comprehensive procedures for shareholder participation:

Voting Timeline

Shareholders can participate through video conferencing, with the facility available for 1,000 members on a first-come, first-served basis. This limitation excludes large shareholders (holding 2% or more), promoters, institutional investors, directors, and key managerial personnel, who can attend without restrictions.

Regulatory Compliance and Publication

The company has fulfilled its regulatory obligations by publishing the EGM notice in newspapers on March 14, 2026, as confirmed by Company Secretary and Compliance Officer Aditya Patel. The EGM notice has been prepared in accordance with:

• Section 108 of the Companies Act, 2013
• SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
• Various MCA circulars issued between 2020-2024
• SEBI circulars on e-voting procedures

CS Vishal Thawani, Practising Company Secretary and Partner of M/s. VTSN and Associates LLP, has been appointed as the Scrutinizer for conducting the remote e-voting process and venue voting system.

Corporate Governance Measures

The company emphasizes that both proposed transactions are conducted at arm's length and in the ordinary course of business. The Audit Committee and Board of Directors have recommended both resolutions after careful consideration of the candidates' qualifications, experience, and contribution to the company's growth initiatives.

Shareholders whose email addresses are not registered with the company or depositories are advised to update their contact information through their respective Depository Participants or by contacting the company's Registrar and Transfer Agent.